Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it's a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Scope of the Report:
Artificial Blood Vessel is a substitute of vascular. It was developed successfully and begins clinical application in the 1950s. Artificial blood vessel requirements include stable physical and chemical properties; mesh suitable degree; have a certain strength and flexibility; easy to sew bypass surgery when making good; no bleeding or oozing blood when small blood vessels and can be turned on instantly stop; after Implantation of human tissue reactions were mild; human tissue can rapidly form the inner and outer membrane newborn; difficult thrombosis; and satisfactory long-term patency. Currently EPTFE, Polyethylene Terephthalate and Polyurethane are used in the manufacture of an artificial blood vessel which is widely used in aortic disease, peripheral vascular disease and hemodialysis.
Consider the global manufacture of Artificial Blood Vessel, Europe and the United States is the major producing regions, the main production companies are concentrated in this area, such as Maquet, Terumo, Gore, B. Braun, Bard, Jotec GmbH, LeMaitre Vascular, Perouse Medical and Nicast. The total production of artificial blood vessel 168450 units in US, whose occupies above 55.69% of total production in 2015. 117300 units were produced in Europe, accounting for more than 38.78% in 2015. 1730 units were produced by Chinese native manufacture in 2015.
The main production areas and consumption areas are concentrated in the United States and European. US and Europe consumption is about 37.50% and 33.26%. The market is mature and stable. China's consumer market share continues to expand. The United States is the world's largest export country, China is still depends on import.
The worldwide market for Artificial Blood Vessel is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new WMR study.
This report focuses on the Artificial Blood Vessel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Peripheral Artery Disease
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Blood Vessel product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Blood Vessel, with price, sales, revenue and global market share of Artificial Blood Vessel in 2017 and 2018.
Chapter 3, the Artificial Blood Vessel competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Blood Vessel breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Artificial Blood Vessel market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Artificial Blood Vessel sales channel, distributors, customers, research findings and conclusion, appendix and data source.